Endotoxin contamination of agaricus blazei murrill extract enhances murine immunologic responses and inhibits the growth of sarcoma 180 implants in vivo

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 29, Issue 2, 2010, Pages 159-168

  Masumoto, Junya ^a,b   Kobayashi, Hitoshi ^b  

^a J   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Agaricus blazei Murrill; Compost; Endotoxin contamination; Sarcoma 180; TNF

Indexed keywords

AGARICUS BLAZEI EXTRACT; ENDOTOXIN; HOT WATER; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGICAL ADJUVANT;

AGARICUS BLAZEI; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CANCER INHIBITION; CELL DEATH; CONTAMINATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL MOUSE; FREEZE DRYING; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; IN VIVO STUDY; INJECTION; MALE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; SARCOMA; SARCOMA 180; SARCOMA CELL; AGARICUS; ANIMAL; BIOSYNTHESIS; FOOD CONTROL; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; PATHOLOGY;

AGARICUS BLAZEI; BASIDIOMYCOTA; MURINAE;

ADJUVANTS, IMMUNOLOGIC; AGARICUS; ANIMALS; ENDOTOXINS; FOOD MICROBIOLOGY; INTERLEUKIN-6; MALE; MICE; MICE, INBRED ICR; SARCOMA 180; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953341897     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v29.i2.80     Document Type: Article

References (30)

1. Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Ito H, Hagiwara T, Nakamura T. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res. 1989;186:267-73.
2. Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1-6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fi brosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol. 1994;66:265-71.
3. Ito H, Shimura K, Itoh H, Kawade M. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) "Himematsutake" and its mechanisms in tumorbearing mice. Anticancer Res. 1997;17:277-84.
4. Mizuno M, Morimoto M, Minato K, Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem. 1998;62:434-7.
5. Fujimiya Y, Suzuki Y, Katakura R, Ebina T. Tumorspecific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazei Murill. Anticancer Res. 1999;19:113-8.
6. Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor beta glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull. 2001;24:820-8.
7. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr. 2001;131:1409-13.
8. Shu CH, Wen BJ. Enhanced shear protection and increased production of an anti-tumor polysaccharide by Agaricus blazei in xanthan-supplemented cultures. Biotechnol Lett. 2003;25:873-6.
9. Lee YL, Kim HJ, Lee MS, Kim JM, Han JS, Hong EK, Kwon MS, Lee MJ. Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma 180 inoculation model. Exp Anim. 2003;52:371-5.
10. Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. Cancer Sci. 2004;95:758-64.
11. Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo. 2005;19:37-60.
12. Jin CY, Choi YH, Moon DO, Park C, Park YM, Jeong SC, Heo MS, Lee TH, Lee JD, Kim GY. Induction of G2/M arrest and apoptosis in human gastric epithelial AGS cells by aqueous extract of Agaricus blazei. Oncol Rep. 2006;16:1349-55.
13. Gonzaga ML, Bezerra DP, Alves AP, de Alencar NM, Mesquita Rde O, Lima MW, Soares Sde A, Pessoa C, de Moraes MO, Costa-Lotufo LVl. In vivo growth-inhibition of Sarcoma 180 by an alpha-(1-4)-glucan-beta-(1-6)-glucan- protein complex polysaccharide obtained from Agaricus blazei Murill. Nat Med (Tokyo). 2009;63:32-40.
14. Ziliotto L, Pinheiro F, Barbisan LF, Rodrigues MA. Screening for in vitro and in vivo antitumor activities of the mushroom Agaricus blazei. Nutr Cancer. 2009;61:245-50.
15. Niu YC, Liu JC, Zhao XM, Su FQ, Cui HX. Immunostimulatory activities of a low molecular weight antitumoral polysaccharide isolated from Agaricus blazei Murill (LMPAB) in Sarcoma 180 ascitic tumor-bearing mice. Pharmazie. 2009;64: 472-6.
16. Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct Funct. 2001;26:103-8.
17. Reid KB, Nolan KF, Lijnen HR, Collen D. Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. Introduction. Methods Enzymol. 1993;223:1-9.
18. Watanabe J, Miyazaki Y, Zimmerman GA, Albertine KH, McIntyre TM. Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J Biol Chem. 2003;278:42361-8.
19. Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TC, Pessoa A Jr. Methods of endotoxin removal from biological preparations: a review. J Pharm Pharm Sci. 2007;10:388-404. (Pubitemid 350079921)
20. Tsan MF, Baochong Gao. Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J Endotoxin Res. 2007;13:6-14.
21. Raetz CR. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol. 1993;175:5745-53.
22. Wolska A, Lech-Maráda E, Robak T. Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett. 2009;14:248-72.
23. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurifi cation of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 2000;165:618-22.
24. Weinstein JR, Swarts S, Bishop C, Hanisch UK, Möller T. Lipopolysaccharide is a frequent and signify cant contaminant in microglia-activating factors. Glia. 2008;56:16-26.
25. van den Berg JH, Quaak SG, Beijnen JH, Beijnen JH, Hennink WE, Storm G, Schumacher TN, Haanen JB, Nuijen B. Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant? Int J Pharm. 2010;390:32-6.
26. Vallabhapurapu S, Karin M. Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693-733.
27. Yamaguchi S, Tanabe K, Takai S, Matsushima-Nishiwaki R, Adachi S, Iida H, Kozawa O, Dohi S. Involvement of Rho-kinase in tumor necrosis factor-α-induced interleukin-6 release from C6 glioma cells. Nerochem Int. 2009;55:438-45.
28. Karin M, Gallagher E. TNFR signaling: ubiquitin-conjugated TRAFfi c signals control stop-andgo for MAPK signaling complexes. Immunol Rev. 2009;228:225-40.
29. Flohé SB, Brüggemann J, Herder C, Goebel C, Kolb H. Enhanced proinfl ammatory response to endotoxin after priming of macrophages with lead ions. J Leukoc Biol. 2002;71:417-24.
30. Engstad CS, Engstad RE, Olsen JO, Osterud B. The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol. 2002;2:1585-97.